Efficacy and safety of maribavir dosed at 100 mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: A randomized, double-blind, multicenter controlled trial

D. J. Winston, F. Saliba, E. Blumberg, M. Abouljoud, J. B. Garcia-Diaz, J. A. Goss, L. Clough, R. Avery, A. P. Limaye, B. G. Ericzon, M. Navasa, R. I. Troisi, H. Chen, S. A. Villano, M. E. Uknis

Research output: Contribution to journal › Article › peer-review